Stage III NSCLC

7 registered clinical trials studyying Stage III NSCLC — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Adjuvant Chemotherapy +/- Cemiplimab and Sequential Hypofractionated Radiotherapy in Unfit or Elderly Patients NCT06656598	Intergroupe Francophone de Cancerologie Thoracique	Phase 2
Recruiting	Neoadjuvant Chemo-immunotherapy for Stage III PD-L1 Positive Non-Small Cell Lung Cancer (NSCLC) NCT07264647	Fondazione Ricerca Traslazionale	Phase 2
Active Not Recruiting	Induction Lorlatinib in Stage III Non-small Cell Lung Cancer NCT05740943	Guangdong Provincial People's Hospital	Phase 2
Terminated	Study of Covalent Menin Inhibitor BMF-219 in Adult Patients With KRAS Driven Non-Small Cell Lung Cancer, Pancr NCT05631574	Biomea Fusion Inc.	Phase 1
Unknown	A Phase 2 Trial of Almonertinib With Concurrent Radiotherapy in The Treatment of Local Advanced EGFR-mutant NS NCT04636593	First People's Hospital of Hangzhou	Phase 2
Withdrawn	Clinical Trial for Evaluating Efficacy and Safety of PDR001 in Concurrent Plus Consolidation Versus Consolidat NCT03945227	Yonsei University	Phase 2
Terminated	Assess the Safety of Immunotherapy Induction With Tremelimumab and Durvalumab Prior to Chemoradiotherapy and/o NCT04287894	The Netherlands Cancer Institute	Phase 1